{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:42:59Z","timestamp":1788385379577,"version":"build-2803163510"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41401-025-01538-2","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T11:20:09Z","timestamp":1744024809000},"page":"2337-2346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Targeting neurodegenerative disease-associated protein aggregation with proximity-inducing modalities"],"prefix":"10.1038","volume":"46","author":[{"given":"Rui-xin","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-bo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"1538_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson 3rd","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I. Hallmarks of neurodegenerative diseases. Cell. 2023;186:693\u2013714.","journal-title":"Cell"},{"key":"1538_CR2","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.stem.2023.03.017","volume":"30","author":"S Temple","year":"2023","unstructured":"Temple S. Advancing cell therapy for neurodegenerative diseases. Cell Stem Cell. 2023;30:512\u201329.","journal-title":"Cell Stem Cell"},{"key":"1538_CR3","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3390\/cells11132091","volume":"11","author":"MY Wendimu","year":"2022","unstructured":"Wendimu MY, Hooks SB. Microglia phenotypes in aging and neurodegenerative diseases. Cells. 2022;11:2091\u2013143.","journal-title":"Cells"},{"key":"1538_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","volume":"7","author":"J Guo","year":"2022","unstructured":"Guo J, Huang X, Dou L, Yan M, Shen T, Tang W, et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct Target Ther. 2022;7:391.","journal-title":"Signal Transduct Target Ther"},{"key":"1538_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s M, Langley DR, Crews CM. PROTAC targeted protein degraders: the past is prologue. Nat Rev Drug Discov. 2022;21:181\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"1538_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6249","volume":"382","author":"G Ahn","year":"2023","unstructured":"Ahn G, Riley NM, Kamber RA, Wisnovsky S, Moncayo von Hase S, Bassik MC, et al. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. Science. 2023;382:eadf6249.","journal-title":"Science"},{"key":"1538_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41401-024-01364-y","volume":"46","author":"YY Li","year":"2025","unstructured":"Li YY, Yang Y, Zhang RS, Ge RX, Xie SB. Targeted degradation of membrane and extracellular proteins with LYTACs. Acta Pharmacol Sin. 2025;46:1\u20137.","journal-title":"Acta Pharmacol Sin"},{"key":"1538_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28520-4","volume":"13","author":"CH Ji","year":"2022","unstructured":"Ji CH, Kim HY, Lee MJ, Heo AJ, Park DY, Lim S, et al. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system. Nat Commun. 2022;13:904.","journal-title":"Nat Commun"},{"key":"1538_CR9","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1016\/j.scib.2023.10.021","volume":"68","author":"S Tan","year":"2023","unstructured":"Tan S, Wang D, Fu Y, Zheng H, Liu Y, Lu B. Targeted clearance of mitochondria by an autophagy-tethering compound (ATTEC) and its potential therapeutic effects. Sci Bull. 2023;68:3013\u201326.","journal-title":"Sci Bull"},{"key":"1538_CR10","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1038\/s41401-024-01326-4","volume":"45","author":"JF Su","year":"2024","unstructured":"Su JF, Xiao Y, Wei LY, Lei HY, Sun F, Wang WX, et al. A new tau dephosphorylation-targeting chimera for the treatment of tauopathies. Acta Pharmacol Sin. 2024;45:2267\u201376.","journal-title":"Acta Pharmacol Sin"},{"key":"1538_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202412925","volume":"63","author":"J Bonet-Aleta","year":"2024","unstructured":"Bonet-Aleta J, Maehara T, Craig BA, Bernardes GJL. Small molecule RNA degraders. Angew Chem Int Ed Engl. 2024;63:e202412925.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1538_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37504-x","volume":"14","author":"L Kiss","year":"2023","unstructured":"Kiss L, Rhinesmith T, Luptak J, Dickson CF, Weidenhausen J, Smyly S, et al. Trim-Away ubiquitinates and degrades lysine-less and N-terminally acetylated substrates. Nat Commun. 2023;14:2160.","journal-title":"Nat Commun"},{"key":"1538_CR13","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1021\/acs.jmedchem.3c01719","volume":"67","author":"W Zhu","year":"2024","unstructured":"Zhu W, Zhang W, Chen J, Tong Y, Xu F, Pang J. Discovery of effective dual PROTAC degraders for neurodegenerative disease-associated aggregates. J Med Chem. 2024;67:3448\u201366.","journal-title":"J Med Chem"},{"key":"1538_CR14","doi-asserted-by":"publisher","first-page":"11454","DOI":"10.1021\/acs.jmedchem.2c00844","volume":"65","author":"Y Fang","year":"2022","unstructured":"Fang Y, Wang J, Zhao M, Zheng Q, Ren C, Wang Y, et al. Progress and challenges in targeted protein degradation for neurodegenerative disease therapy. J Med Chem. 2022;65:11454\u201377.","journal-title":"J Med Chem"},{"key":"1538_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-022-00966-4","volume":"7","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhao J, Zhong K, Tong A, Jia D. Targeted protein degradation: mechanisms, strategies and application. Signal Transduct Target Ther. 2022;7:113.","journal-title":"Signal Transduct Target Ther"},{"key":"1538_CR16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.tins.2023.07.009","volume":"46","author":"J Singh","year":"2023","unstructured":"Singh J, Habean ML, Panicker N. Inflammasome assembly in neurodegenerative diseases. Trends Neurosci. 2023;46:814\u201331.","journal-title":"Trends Neurosci"},{"key":"1538_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.cell.2023.01.005","volume":"186","author":"ST Hung","year":"2023","unstructured":"Hung ST, Linares GR, Chang WH, Eoh Y, Krishnan G, Mendonca S, et al. PIKFYVE inhibition mitigates disease in models of diverse forms of ALS. Cell. 2023;186:786\u2013802.","journal-title":"Cell"},{"key":"1538_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2023.11.029","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen Y, Song S, Parhizkar S, Lord J, Zhu Y, Strickland MR, et al. APOE3ch alters microglial response and suppresses A\u03b2-induced tau seeding and spread. Cell. 2024;187:428\u201345.","journal-title":"Cell"},{"key":"1538_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol. 2022;21:726\u201334.","journal-title":"Lancet Neurol"},{"key":"1538_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.medp.2024.100005","volume":"1","author":"Q Li","year":"2024","unstructured":"Li Q, Pan W, Zhou J, Yu H, Xie S. Targeting protein aggregation for the treatment of neurodegenerative diseases. Med Plus. 2024;1:100005.","journal-title":"Med Plus"},{"key":"1538_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH. The pathogenesis of Parkinson\u2019s disease. Lancet. 2024;403:293\u2013304.","journal-title":"Lancet"},{"key":"1538_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, et al. Potential disease-modifying therapies for Huntington\u2019s disease: lessons learned and future opportunities. Lancet Neurol. 2022;21:645\u201358.","journal-title":"Lancet Neurol"},{"key":"1538_CR23","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1016\/j.cell.2023.08.021","volume":"186","author":"M Jucker","year":"2023","unstructured":"Jucker M, Walker LC. Alzheimer\u2019s disease: from immunotherapy to immunoprevention. Cell. 2023;186:4260\u201370.","journal-title":"Cell"},{"key":"1538_CR24","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.3390\/cells12232726","volume":"12","author":"E Knezevic","year":"2023","unstructured":"Knezevic E, Nenic K, Milanovic V, Knezevic NN. The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells. 2023;12:2726.","journal-title":"Cells"},{"key":"1538_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","volume":"25","author":"C Parra Bravo","year":"2024","unstructured":"Parra Bravo C, Naguib SA, Gan L. Cellular and pathological functions of tau. Nat Rev Mol Cell Biol. 2024;25:845\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1538_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2310067120","volume":"120","author":"P Duan","year":"2023","unstructured":"Duan P, Dregni AJ, Mammeri NE, Hong M. Structure of the nonhelical filament of the Alzheimer\u2019s disease tau core. Proc Natl Acad Sci USA. 2023;120:e2310067120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1538_CR27","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1073\/pnas.1221891110","volume":"110","author":"K Sathasivam","year":"2013","unstructured":"Sathasivam K, Neueder A, Gipson TA, Landles C, Benjamin AC, Bondulich MK, et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci USA. 2013;110:2366\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1538_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell. 2006;125:1179\u201391.","journal-title":"Cell"},{"key":"1538_CR29","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/brain\/awae063","volume":"147","author":"SG Aldous","year":"2024","unstructured":"Aldous SG, Smith EJ, Landles C, Osborne GF, Ca\u00f1ibano-Pico M, Nita IM, et al. A CAG repeat threshold for therapeutics targeting somatic instability in Huntington\u2019s disease. Brain. 2024;147:1784\u201398.","journal-title":"Brain"},{"key":"1538_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41556-024-01414-x","volume":"26","author":"R Aviner","year":"2024","unstructured":"Aviner R, Lee TT, Masto VB, Li KH, Andino R, Frydman J. Polyglutamine-mediated ribotoxicity disrupts proteostasis and stress responses in Huntington\u2019s disease. Nat Cell Biol. 2024;26:892\u2013902.","journal-title":"Nat Cell Biol"},{"key":"1538_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112787","volume":"43","author":"I Harel","year":"2024","unstructured":"Harel I, Chen YR, Ziv I, Singh PP, Heinzer D, Navarro Negredo P, et al. Identification of protein aggregates in the aging vertebrate brain with prion-like and phase-separation properties. Cell Rep. 2024;43:112787.","journal-title":"Cell Rep"},{"key":"1538_CR32","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1074\/jbc.RA118.004511","volume":"294","author":"M Lu","year":"2019","unstructured":"Lu M, Williamson N, Mishra A, Michel CH, Kaminski CF, Tunnacliffe A, et al. Structural progression of amyloid-\u03b2 Arctic mutant aggregation in cells revealed by multiparametric imaging. J Biol Chem. 2019;294:1478\u201387.","journal-title":"J Biol Chem"},{"key":"1538_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21:480\u201393.","journal-title":"Lancet Neurol"},{"key":"1538_CR34","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","volume":"98","author":"KM Sakamoto","year":"2001","unstructured":"Sakamoto KM, Kim KB, Kumagai A, Mercurio F, Crews CM, Deshaies RJ. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc Natl Acad Sci USA. 2001;98:8554\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1538_CR35","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.tips.2023.05.008","volume":"44","author":"Z Yang","year":"2023","unstructured":"Yang Z, Pang Q, Zhou J, Xuan C, Xie S. Leveraging aptamers for targeted protein degradation. Trends Pharmacol Sci. 2023;44:776\u201385.","journal-title":"Trends Pharmacol Sci"},{"key":"1538_CR36","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1021\/acs.jmedchem.2c01557","volume":"66","author":"M Chen","year":"2023","unstructured":"Chen M, Zhou P, Kong Y, Li J, Li Y, Zhang Y, et al. Inducible degradation of oncogenic nucleolin using an aptamer-based PROTAC. J Med Chem. 2023;66:1339\u201348.","journal-title":"J Med Chem"},{"key":"1538_CR37","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.scib.2024.05.017","volume":"69","author":"L Kong","year":"2024","unstructured":"Kong L, Meng F, Zhou P, Ge R, Geng X, Yang Z, et al. An engineered DNA aptamer-based PROTAC for precise therapy of p53-R175H hotspot mutant-driven cancer. Sci Bull. 2024;69:2122\u201335.","journal-title":"Sci Bull"},{"key":"1538_CR38","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.chembiol.2016.02.016","volume":"23","author":"TT Chu","year":"2016","unstructured":"Chu TT, Gao N, Li QQ, Chen PG, Yang XF, Chen YX, et al. Specific Knockdown of endogenous Tau protein by peptide-directed ubiquitin-proteasome degradation. Cell Chem Biol. 2016;23:453\u201361.","journal-title":"Cell Chem Biol"},{"key":"1538_CR39","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejmech.2018.01.063","volume":"146","author":"M Lu","year":"2018","unstructured":"Lu M, Liu T, Jiao Q, Ji J, Tao M, Liu Y, et al. Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway. Eur J Med Chem. 2018;146:251\u20139.","journal-title":"Eur J Med Chem"},{"key":"1538_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.801179","volume":"16","author":"MC Silva","year":"2022","unstructured":"Silva MC, Nandi G, Donovan KA, Cai Q, Berry BC, Nowak RP, et al. Discovery and optimization of Tau targeted protein degraders enabled by patient induced pluripotent stem cells-derived neuronal models of tauopathy. Front Cell Neurosci. 2022;16:801179.","journal-title":"Front Cell Neurosci"},{"key":"1538_CR41","doi-asserted-by":"publisher","first-page":"5279","DOI":"10.7150\/thno.55680","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Zhou Q, Jiang T, Li S, Ye J, Zheng J, et al. A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models. Theranostics. 2021;11:5279\u201395.","journal-title":"Theranostics"},{"key":"1538_CR42","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.chembiol.2020.05.012","volume":"27","author":"J Qu","year":"2020","unstructured":"Qu J, Ren X, Xue F, He Y, Zhang R, Zheng Y, et al. Specific knockdown of \u03b1-synuclein by peptide-directed proteasome degradation rescued its associated neurotoxicity. Cell Chem Biol. 2020;27:763.","journal-title":"Cell Chem Biol"},{"key":"1538_CR43","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1021\/acs.jmedchem.3c00274","volume":"66","author":"Y Tong","year":"2023","unstructured":"Tong Y, Zhu W, Chen J, Wen T, Xu F, Pang J. Discovery of small-molecule degraders for alpha-synuclein aggregates. J Med Chem. 2023;66:7926\u201342.","journal-title":"J Med Chem"},{"key":"1538_CR44","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.1002\/anie.201706529","volume":"56","author":"S Tomoshige","year":"2017","unstructured":"Tomoshige S, Nomura S, Ohgane K, Hashimoto Y, Ishikawa M. Discovery of small molecules that induce the degradation of Huntingtin. Angew Chem Int Ed Engl. 2017;56:11530\u20133.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1538_CR45","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.bmcl.2018.01.012","volume":"28","author":"S Tomoshige","year":"2018","unstructured":"Tomoshige S, Nomura S, Ohgane K, Hashimoto Y, Ishikawa M. Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative. Bioorg Med Chem Lett. 2018;28:707\u201310.","journal-title":"Bioorg Med Chem Lett"},{"key":"1538_CR46","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400:1363\u201380.","journal-title":"Lancet"},{"key":"1538_CR47","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.neuron.2023.02.028","volume":"111","author":"D Piol","year":"2023","unstructured":"Piol D, Robberechts T, Da Cruz S. Lost in local translation: TDP-43 and FUS in axonal\/neuromuscular junction maintenance and dysregulation in amyotrophic lateral sclerosis. Neuron. 2023;111:1355\u201380.","journal-title":"Neuron"},{"key":"1538_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12929-023-00921-7","volume":"30","author":"YL Tseng","year":"2023","unstructured":"Tseng YL, Lu PC, Lee CC, He RY, Huang YA, Tseng YC, et al. Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera. J Biomed Sci. 2023;30:27.","journal-title":"J Biomed Sci"},{"key":"1538_CR49","doi-asserted-by":"publisher","first-page":"40362","DOI":"10.1039\/C7RA05347A","volume":"7","author":"N Gao","year":"2017","unstructured":"Gao N, Chu TT, Li QQ, Lim YJ, Qiu T, Ma MR, et al. Hydrophobic tagging-mediated degradation of Alzheimer\u2019s disease related Tau. RSC Adv. 2017;7:40362\u20136.","journal-title":"RSC Adv"},{"key":"1538_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.bioorg.2018.11.042","volume":"84","author":"N Gao","year":"2019","unstructured":"Gao N, Huang YP, Chu TT, Li QQ, Zhou B, Chen YX, et al. TDP-43 specific reduction induced by Di-hydrophobic tags conjugated peptides. Bioorg Chem. 2019;84:254\u20139.","journal-title":"Bioorg Chem"},{"key":"1538_CR51","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3390\/cells13090731","volume":"13","author":"J Jeong","year":"2024","unstructured":"Jeong J, Usman M, Li Y, Zhou XZ, Lu KP. Pin1-catalyzed conformation changes regulate protein ubiquitination and degradation. Cells. 2024;13:731.","journal-title":"Cells"},{"key":"1538_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2023.104776","volume":"393-394","author":"E Holwek","year":"2023","unstructured":"Holwek E, Opinc-Rosiak A, Sarnik J, Makowska J. Ro52\/TRIM21 - From host defense to autoimmunity. Cell Immunol. 2023;393-394:104776.","journal-title":"Cell Immunol"},{"key":"1538_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112125","volume":"42","author":"TET Mevissen","year":"2023","unstructured":"Mevissen TET, Prasad AV, Walter JC. TRIM21-dependent target protein ubiquitination mediates cell-free Trim-Away. Cell Rep. 2023;42:112125.","journal-title":"Cell Rep"},{"key":"1538_CR54","doi-asserted-by":"publisher","first-page":"14343","DOI":"10.1074\/jbc.RA119.011006","volume":"295","author":"S Xie","year":"2020","unstructured":"Xie S, Zhang L, Dong D, Ge R, He Q, Fan C, et al. HDAC6 regulates antibody-dependent intracellular neutralization of viruses via deacetylation of TRIM21. J Biol Chem. 2020;295:14343\u201351.","journal-title":"J Biol Chem"},{"key":"1538_CR55","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1126\/science.adp5186","volume":"385","author":"J Benn","year":"2024","unstructured":"Benn J, Cheng S, Keeling S, Smith AE, Vaysburd MJ, B\u00f6ken D, et al. Aggregate-selective removal of pathological tau by clustering-activated degraders. Science. 2024;385:1009\u201316.","journal-title":"Science"},{"key":"1538_CR56","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1016\/j.cell.2024.08.024","volume":"187","author":"LVC Miller","year":"2024","unstructured":"Miller LVC, Papa G, Vaysburd M, Cheng S, Sweeney PW, Smith A, et al. Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function. Cell. 2024;187:5967\u201380.","journal-title":"Cell"},{"key":"1538_CR57","doi-asserted-by":"publisher","first-page":"9278","DOI":"10.1021\/acs.jmedchem.3c00449","volume":"66","author":"JA Dewey","year":"2023","unstructured":"Dewey JA, Delalande C, Azizi SA, Lu V, Antonopoulos D, Babnigg G. Molecular glue discovery: current and future approaches. J Med Chem. 2023;66:9278\u201396.","journal-title":"J Med Chem"},{"key":"1538_CR58","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.cell.2024.10.015","volume":"187","author":"P Lu","year":"2024","unstructured":"Lu P, Cheng Y, Xue L, Ren X, Xu X, Chen C, et al. Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders. Cell. 2024;187:7126\u201342.","journal-title":"Cell"},{"key":"1538_CR59","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41580-024-00757-5","volume":"25","author":"RA Nixon","year":"2024","unstructured":"Nixon RA, Rubinsztein DC. Mechanisms of autophagy-lysosome dysfunction in neurodegenerative diseases. Nat Rev Mol Cell Biol. 2024;25:926\u201346.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1538_CR60","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nn.3637","volume":"17","author":"X Fan","year":"2014","unstructured":"Fan X, Jin WY, Lu J, Wang J, Wang YT. Rapid and reversible knockdown of endogenous proteins by peptide-directed lysosomal degradation. Nat Neurosci. 2014;17:471\u201380.","journal-title":"Nat Neurosci"},{"key":"1538_CR61","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nbt.1608","volume":"28","author":"PO Bauer","year":"2010","unstructured":"Bauer PO, Goswami A, Wong HK, Okuno M, Kurosawa M, Yamada M, et al. Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat Biotechnol. 2010;28:256\u201363.","journal-title":"Nat Biotechnol"},{"key":"1538_CR62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-023-00630-7","volume":"18","author":"J Lee","year":"2023","unstructured":"Lee J, Sung KW, Bae EJ, Yoon D, Kim D, Lee JS, et al. Targeted degradation of \u03b1-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology. Mol Neurodegener. 2023;18:41.","journal-title":"Mol Neurodegener"},{"key":"1538_CR63","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1080\/15548627.2023.2234797","volume":"19","author":"L Mei","year":"2023","unstructured":"Mei L, Chen X, Wei F, Huang X, Liu L, Yao J, et al. Tethering ATG16L1 or LC3 induces targeted autophagic degradation of protein aggregates and mitochondria. Autophagy. 2023;19:2997\u20133013.","journal-title":"Autophagy"},{"key":"1538_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","volume":"575","author":"Z Li","year":"2019","unstructured":"Li Z, Wang C, Wang Z, Zhu C, Li J, Sha T, et al. Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds. Nature. 2019;575:203\u20139.","journal-title":"Nature"},{"key":"1538_CR65","first-page":"24785","volume":"145","author":"H He","year":"2023","unstructured":"He H, Zhou C, Chen X. ATNC: versatile nanobody chimeras for autophagic degradation of intracellular unligandable and undruggable proteins. J Am Chem Soc. 2023;145:24785\u201395.","journal-title":"J Am Chem Soc"},{"key":"1538_CR66","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","volume":"638","author":"D Zhang","year":"2025","unstructured":"Zhang D, Duque-Jimenez J, Facchinetti F, Brixi G, Rhee K, Feng WW, et al. Transferrin receptor targeting chimeras for membrane protein degradation. Nature. 2025;638:787\u201395.","journal-title":"Nature"},{"key":"1538_CR67","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41586-024-07948-2","volume":"638","author":"B Huang","year":"2025","unstructured":"Huang B, Abedi M, Ahn G, Coventry B, Sappington I, Tang C, et al. Designed endocytosis-inducing proteins degrade targets and amplify signals. Nature. 2025;638:796\u2013804.","journal-title":"Nature"},{"key":"1538_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41593-022-01239-7","volume":"26","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zhu R, Pan B, Xu H, Olufemi MF, Gathagan RJ, et al. Post-translational modifications of soluble \u03b1-synuclein regulate the amplification of pathological \u03b1-synuclein. Nat Neurosci. 2023;26:213\u201325.","journal-title":"Nat Neurosci"},{"key":"1538_CR69","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.cell.2020.10.029","volume":"183","author":"H Wesseling","year":"2020","unstructured":"Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, et al. Tau PTM profiles identify patient heterogeneity and stages of Alzheimer\u2019s disease. Cell. 2020;183:1699\u2013713.","journal-title":"Cell"},{"key":"1538_CR70","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41392-021-00669-2","volume":"6","author":"J Zheng","year":"2021","unstructured":"Zheng J, Tian N, Liu F, Zhang Y, Su J, Gao Y, et al. A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies. Signal Transduct Target Ther. 2021;6:269.","journal-title":"Signal Transduct Target Ther"},{"key":"1538_CR71","doi-asserted-by":"crossref","unstructured":"Hu Z, Chen PH, Li W, Douglas T, Hines J, Liu Y, et al. Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a therapeutic modality. J Am Chem Soc. 2023;145:4045\u201355.","DOI":"10.1021\/jacs.2c11706"},{"key":"1538_CR72","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.scib.2024.01.019","volume":"69","author":"J Su","year":"2024","unstructured":"Su J, Xiao Y, Wei L, Lei H, Sun F, Wang W, et al. Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer\u2019s disease and related tauopathies. Sci Bull. 2024;69:1137\u201352.","journal-title":"Sci Bull"},{"key":"1538_CR73","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2306682120","volume":"121","author":"Y Tong","year":"2024","unstructured":"Tong Y, Zhang P, Yang X, Liu X, Zhang J, Grudniewska M, et al. Decreasing the intrinsically disordered protein \u03b1-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera. Proc Natl Acad Sci USA. 2024;121:e2306682120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1538_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd5991","volume":"13","author":"JA Bush","year":"2021","unstructured":"Bush JA, Aikawa H, Fuerst R, Li Y, Ursu A, Meyer SM, et al. Ribonuclease recruitment using a small molecule reduced c9ALS\/FTD r(G(4)C(2)) repeat expansion in vitro and in vivo ALS models. Sci Transl Med. 2021;13:eabd5991.","journal-title":"Sci Transl Med"},{"key":"1538_CR75","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1021\/acs.jmedchem.2c00691","volume":"65","author":"Y Li","year":"2022","unstructured":"Li Y, Song J, Zhou P, Zhou J, Xie S. Targeting undruggable transcription factors with PROTACs: advances and perspectives. J Med Chem. 2022;65:10183\u201394.","journal-title":"J Med Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01538-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:22:07Z","timestamp":1757161327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01538-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1538"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01538-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"19 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}